Cell type-specific regulation of IL-10 expression in inflammation and disease
- PMID: 20087682
- PMCID: PMC2892196
- DOI: 10.1007/s12026-009-8150-5
Cell type-specific regulation of IL-10 expression in inflammation and disease
Abstract
IL-10 plays an essential part in controlling inflammation and instructing adaptive immune responses. Consequently, dysregulation of IL-10 is linked with susceptibility to numerous infectious and autoimmune diseases in mouse models and in humans. It has become increasingly clear that appropriate temporal/spatial expression of IL-10 may be the key to how IL-10 contributes to the delicate balance between inflammation and immunoregulation. The mechanisms that govern the cell type- and receptor-specific induction of IL-10, however, remain unclear. This is due largely to the wide distribution of cellular sources that express IL-10 under diverse stimulation conditions and in a variety of tissue compartments. Further complicating the issue is the fact that human IL-10 expression patterns appear to be under genetic influence resulting in differential expression and disease susceptibility. In this review, we discuss the cellular sources of IL-10, their link to disease phenotypes and the molecular mechanisms implicated in IL-10 regulation.
Figures


Similar articles
-
IL-10-producing lymphocytes in inflammatory disease.Int Rev Immunol. 2013 Jun;32(3):324-36. doi: 10.3109/08830185.2012.762361. Epub 2013 Apr 25. Int Rev Immunol. 2013. PMID: 23617759 Review.
-
Transcriptional regulation of IL-10 and its cell-specific role in vivo.Crit Rev Immunol. 2014;34(4):315-45. doi: 10.1615/critrevimmunol.2014010694. Crit Rev Immunol. 2014. PMID: 24941159 Review.
-
IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage.J Clin Invest. 2004 Nov;114(10):1372-8. doi: 10.1172/JCI23215. J Clin Invest. 2004. PMID: 15545984 Free PMC article. Review.
-
Toll-Like Receptor 2-Tpl2-Dependent ERK Signaling Drives Inverse Interleukin 12 Regulation in Dendritic Cells and Macrophages.Infect Immun. 2020 Dec 15;89(1):e00323-20. doi: 10.1128/IAI.00323-20. Print 2020 Dec 15. Infect Immun. 2020. PMID: 33077627 Free PMC article.
-
Abrogation of anti-retinal autoimmunity in IL-10 transgenic mice due to reduced T cell priming and inhibition of disease effector mechanisms.J Immunol. 2008 Apr 15;180(8):5423-9. doi: 10.4049/jimmunol.180.8.5423. J Immunol. 2008. PMID: 18390724 Free PMC article.
Cited by
-
IL-10 from dendritic cells but not from T regulatory cells protects against cisplatin-induced nephrotoxicity.PLoS One. 2020 Sep 8;15(9):e0238816. doi: 10.1371/journal.pone.0238816. eCollection 2020. PLoS One. 2020. PMID: 32898157 Free PMC article.
-
Sevoflurane modulates AQPs (1,5) expression and endoplasmic reticulum stress in mice lung with allergic airway inflammation.Biosci Rep. 2019 Nov 29;39(11):BSR20193282. doi: 10.1042/BSR20193282. Biosci Rep. 2019. PMID: 31710085 Free PMC article.
-
Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumab.MAbs. 2014 May-Jun;6(3):783-93. doi: 10.4161/mabs.28376. Epub 2014 Mar 4. MAbs. 2014. PMID: 24594862 Free PMC article. Clinical Trial.
-
Multiple roles of cardiac macrophages in heart homeostasis and failure.Heart Fail Rev. 2022 Jul;27(4):1413-1430. doi: 10.1007/s10741-021-10156-z. Epub 2021 Aug 13. Heart Fail Rev. 2022. PMID: 34387811 Free PMC article. Review.
-
Long Intergenic Non-Coding RNAs: Novel Drivers of Human Lymphocyte Differentiation.Front Immunol. 2015 Apr 15;6:175. doi: 10.3389/fimmu.2015.00175. eCollection 2015. Front Immunol. 2015. PMID: 25926836 Free PMC article. Review.
References
-
- Moore KW, De Waal MR, Coffman RL, O’Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683–765. - PubMed
-
- Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol. 2004;22:929–79. - PubMed
-
- Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol. 1991;147:3815–22. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical